BC
Birchview Capital Portfolio holdings
AUM
$132M
1-Year Est. Return
53.17%
1 Year Est. Return
+53.17%
AUM
$101M
AUM Growth
-$14.5M
(-13%)
Holding
80
Top Buys
| 1 | +$14.2M | |
| 2 | +$2.1M | |
| 3 | +$1.25M | |
| 4 |
Freeport-McMoran
FCX
|
+$782K |
| 5 |
Structure Therapeutics
GPCR
|
+$747K |
Top Sells
| 1 | +$16.7M | |
| 2 | +$1.63M | |
| 3 | +$934K | |
| 4 |
Travere Therapeutics
TVTX
|
+$518K |
| 5 |
Masimo
MASI
|
+$505K |
Sector Composition
| 1 | Healthcare | 79.06% |
| 2 | Technology | 14.1% |
| 3 | Energy | 6.07% |
| 4 | Materials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$99B
| $15M | 14.86% |
323,358
-361,834
|
|
||
2
KLA
KLAC
$153B
| $14.2M | 14.1% |
+15,848
|
|
||
3
Corcept Therapeutics
CORT
$7.97B
| $4.93M | 4.9% |
67,200
+1,200
|
|
||
4
Ovintiv
OVV
$9.83B
| $4.09M | 4.06% |
107,500
+55,300
|
|
||
5
Acadia Pharmaceuticals
ACAD
$4B
| $4.05M | 4.02% |
187,800
-75,600
|
|
||
6
Neurocrine Biosciences
NBIX
$14.4B
| $3.89M | 3.86% |
30,940
+700
|
|
||
7
Phreesia
PHR
$1.35B
| $3.26M | 3.24% |
114,700
|
|
||
8
Prothena Corp
PRTA
$548M
| $2.74M | 2.72% |
451,019
+118,045
|
|
||
9
Protagonist Therapeutics
PTGX
$5.2B
| $2.65M | 2.63% |
48,000
-2
|
|
||
10
Stoke Therapeutics
STOK
$1.49B
| $2.38M | 2.37% |
210,000
-5
|
|
||
11
Elutia
ELUT
$31.5M
| $2.29M | 2.28% |
1,159,059
-28,676
|
|
||
12
Castle Biosciences
CSTL
$996M
| $2.26M | 2.24% |
110,600
+22,196
|
|
||
13
QuidelOrtho
QDEL
$1.51B
| $2.09M | 2.08% |
72,548
+4,929
|
|
||
14
EQT Corp
EQT
$37.6B
| $2.02M | 2.01% |
34,619
|
|
||
15
Harrow
HROW
$1.4B
| $1.83M | 1.82% |
60,000
-12,910
|
|
||
16
NovoCure
NVCR
$1.27B
| $1.8M | 1.79% |
101,000
+70,000
|
|
||
17
Axogen
AXGN
$1.11B
| $1.75M | 1.73% |
161,000
|
|
||
18
Biodesix
BDSX
$62.8M
| $1.62M | 1.61% |
286,806
|
|
||
|
19
Travere Therapeutics
TVTX
$3.03B
| $1.52M | 1.51% |
103,000
-35,000
|
|
||
20
Foghorn Therapeutics
FHTX
$247M
| $1.46M | 1.45% |
310,930
|
|
||
21
Alkermes
ALKS
$5.12B
| $1.43M | 1.42% |
50,000
|
|
||
|
22
Masimo
MASI
$8.19B
| $1.39M | 1.38% |
8,280
-3,000
|
|
||
23
uniQure
QURE
$1.89B
| $1.38M | 1.37% |
98,697
+10,000
|
|
||
24
United Therapeutics
UTHR
$19.9B
| $1.22M | 1.21% |
4,250
-3,250
|
|
||
25
DocGo
DCGO
$102M
| $1.2M | 1.19% |
764,062
-100,000
|
|